Global Cell Therapy Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Cell Therapy market size will reach 159,413 Million USD in 2025 and is projected to reach 405,804 Million USD by 2032, with a CAGR of 14.28% (2025-2032). Notably, the China Cell Therapy market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Cell therapy, also known as cellular therapy, is a therapeutic approach that utilizes living cells to treat or prevent diseases and disorders. It involves the administration of cells, either autologous (derived from the patient) or allogeneic (donor-derived), with the aim of replacing damaged or dysfunctional cells, stimulating the body's immune response, or delivering therapeutic molecules. Cell therapy encompasses a wide range of techniques and applications, including stem cell therapy, immunotherapy, and regenerative medicine. Stem cell therapy involves the use of stem cells, which have the potential to differentiate into various cell types, to repair or regenerate damaged tissues or organs. Immunotherapy utilizes immune cells or engineered cells to enhance the immune system's ability to recognize and eliminate cancer cells or other pathogens. Regenerative medicine focuses on using cells to stimulate tissue repair or promote the regeneration of damaged tissues or organs. Cell therapy holds promise for treating a variety of conditions, including cancer, genetic disorders, autoimmune diseases, neurodegenerative disorders, and cardiovascular diseases, and represents a rapidly evolving field at the forefront of medical research and innovation.
The major global suppliers of Cell Therapy include Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Cell Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Cell Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Cell Therapy Include:
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Cell Therapy Product Segment Include:
Stem Cell
Non-Stem Cell
Cell Therapy Product Application Include:
Hospital
Clinic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Cell Therapy Industry PESTEL Analysis
Chapter 3: Global Cell Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Cell Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Cell Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Cell Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Cell Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Cell Therapy market size will reach 159,413 Million USD in 2025 and is projected to reach 405,804 Million USD by 2032, with a CAGR of 14.28% (2025-2032). Notably, the China Cell Therapy market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Cell therapy, also known as cellular therapy, is a therapeutic approach that utilizes living cells to treat or prevent diseases and disorders. It involves the administration of cells, either autologous (derived from the patient) or allogeneic (donor-derived), with the aim of replacing damaged or dysfunctional cells, stimulating the body's immune response, or delivering therapeutic molecules. Cell therapy encompasses a wide range of techniques and applications, including stem cell therapy, immunotherapy, and regenerative medicine. Stem cell therapy involves the use of stem cells, which have the potential to differentiate into various cell types, to repair or regenerate damaged tissues or organs. Immunotherapy utilizes immune cells or engineered cells to enhance the immune system's ability to recognize and eliminate cancer cells or other pathogens. Regenerative medicine focuses on using cells to stimulate tissue repair or promote the regeneration of damaged tissues or organs. Cell therapy holds promise for treating a variety of conditions, including cancer, genetic disorders, autoimmune diseases, neurodegenerative disorders, and cardiovascular diseases, and represents a rapidly evolving field at the forefront of medical research and innovation.
The major global suppliers of Cell Therapy include Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Cell Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Cell Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Cell Therapy Include:
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Cell Therapy Product Segment Include:
Stem Cell
Non-Stem Cell
Cell Therapy Product Application Include:
Hospital
Clinic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Cell Therapy Industry PESTEL Analysis
Chapter 3: Global Cell Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Cell Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Cell Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Cell Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Cell Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Cell Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Cell Therapy Product by Type
- 1.2.1 Stem Cell
- 1.2.2 Non-Stem Cell
- 1.3 Cell Therapy Product by Application
- 1.3.1 Hospital
- 1.3.2 Clinic
- 1.4 Global Cell Therapy Market Size Analysis (2020-2032)
- 1.5 Cell Therapy Market Development Status and Trends
- 1.5.1 Cell Therapy Industry Development Status Analysis
- 1.5.2 Cell Therapy Industry Development Trends Analysis
- 2 Cell Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Cell Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Cell Therapy Market Analysis by Country
- 4.1 Global Cell Therapy Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Cell Therapy Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Cell Therapy Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.5 China Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.6 France Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.14 India Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Cell Therapy Market Revenue by Key Suppliers (2021-2025)
- 5.2 Cell Therapy Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Cell Therapy Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Cell Therapy Market Analysis by Type
- 6.1 Global Cell Therapy Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Cell Therapy Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Gilead Sciences
- 7.1.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Gilead Sciences Cell Therapy Product Portfolio
- 7.1.3 Gilead Sciences Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Novartis
- 7.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Novartis Cell Therapy Product Portfolio
- 7.2.3 Novartis Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Osiris
- 7.3.1 Osiris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Osiris Cell Therapy Product Portfolio
- 7.3.3 Osiris Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Vericel Corporation
- 7.4.1 Vericel Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Vericel Corporation Cell Therapy Product Portfolio
- 7.4.3 Vericel Corporation Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Vcanbio
- 7.5.1 Vcanbio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Vcanbio Cell Therapy Product Portfolio
- 7.5.3 Vcanbio Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Fujifilm Cellular Dynamics
- 7.6.1 Fujifilm Cellular Dynamics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Fujifilm Cellular Dynamics Cell Therapy Product Portfolio
- 7.6.3 Fujifilm Cellular Dynamics Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 JCR Pharmaceuticals
- 7.7.1 JCR Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 JCR Pharmaceuticals Cell Therapy Product Portfolio
- 7.7.3 JCR Pharmaceuticals Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Beike Biotechnology
- 7.8.1 Beike Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Beike Biotechnology Cell Therapy Product Portfolio
- 7.8.3 Beike Biotechnology Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Golden Meditech
- 7.9.1 Golden Meditech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Golden Meditech Cell Therapy Product Portfolio
- 7.9.3 Golden Meditech Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Guanhao Biotech
- 7.10.1 Guanhao Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Guanhao Biotech Cell Therapy Product Portfolio
- 7.10.3 Guanhao Biotech Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Cell Therapy Industry Chain Analysis
- 8.2 Cell Therapy Product Downstream Application Analysis
- 8.2.1 Global Cell Therapy Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Cell Therapy Revenue and Forecast by Application (2020-2032)
- 8.3 Cell Therapy Typical Downstream Customers
- 8.4 Cell Therapy Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
